Oral and nasal immunization with microencapsulated clinically relevant proteins

S.T.P. Pharma Sciences

Volumn 8, Issue 1, 1998, Pages 31-39

  Alpar, H O ^a   Eyles, J E ^a   Williamson, E D ^b  

^a ASTON UNIVERSITY   (United Kingdom)

^b DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

Author keywords

Biodegradable particles; Cholera toxin; Common mucosal immune system; Intranasal; Mucosal immunity; Oral; Protective subunits; Vaccines; Yersinia pestis

Indexed keywords

BACTERIAL ANTIGEN; DRUG CARRIER; HEMAGGLUTININ; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MICROSPHERE; PERTUSSIS TOXIN; PHOSPHORYLCHOLINE; POLY(DESAMINOTYROSYLTYROSINE HEXYLCARBONATE ESTER); POLYGLACTIN; POLYMER; POLYSTYRENE; PROTEIN; RICIN; STAPHYLOCOCCUS ENTEROTOXIN B; TETANUS TOXOID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; BORDETELLA PERTUSSIS; DRUG DELIVERY SYSTEM; FIMBRIA; IMMUNIZATION; INTRANASAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; LYMPHOID TISSUE; MICROENCAPSULATION; MOUSE; MUCOSA; NONHUMAN; ORAL DRUG ADMINISTRATION; PARTICLE SIZE; REVIEW; YERSINIA PESTIS;

EID: 0031893088     PISSN: 11571489     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. MORRIS W., STEINHOFF M.C. and RUSSELL P.K. - Potential of polymer microencapsulation technology for vaccine innovation. - Vaccine, 12, 5-11, 1994.
2. ELDRIDGE J.H., STAAS J.K., CHEN D.,MARX P.A., TICET.R. and GILLEY R.M. - New advances in vaccine delivery systems. -Seminars in Hematology, 30, 16-25 1993.
3. ALMEIDA A.J. and ALPAR H.O. - Mucosal immunization with antigen-containing microspheres. - In: Antigen Delivery Systems, Harwood Academic Press, Zurich (in press).
4. BIENENSTOCK J.-The nature of immunity at mucosal surfaces. A brief review. - In: Bacterial Infections of the Respiratory and Gastrointestinal Mucosae, W. Donachie, E. Griffiths and J. Stephen Eds., IRL Press, Oxford, 1988, pp. 9-18.
5. BIENENSTOCK J. and JOHNSTON N. - A morphologic study of rabbit bronchial lymphoid aggregates and lymphoepithelium. -Laboratory Investigation, 35, 343-348, 1976.
6. HOLMGREN J., CZERKINSKY C., LYCKE N. and SVENNERHOLM A. - Mucosal immunity: implications for vaccine development. - Immunobiology, 184, 157-179, 1992.
7. WOLF J.L. and BYE W.A. - The membranes epithelial (M) cells and mucosal immune system. - Annual Rev. Med, 35, 95-112, 1984.
8. McCLUGGAGE S.G., LOW F.N. and ZIMMY M.L. - Porosity of the basement membrane overlying Peyer's patches in rats and monkeys. - Gastroenterology, 91, 1128-1133, 1986.
9. ELDRIDGE J.H., GILLEY R.M., STAAS J.K., MOLDOVEANU Z., MEULBROEK J.A. and TICE T.R. - Biodegradable microspheres: vaccine delivery systems fororal immunization. -Current Topics in Microbiology and Immunol., 146, 59-66, 1989.
10. SPIT B.J., HENDRIKSEN E.G.J., BRUIJNTJES J.P. and KUPER C.F. - Nasal lymphoid tissue in the rat. - Cell and Tissue Res., 255, 193-198, 1989.
11. KUPER C.F., HAMELEERS D.M.H., BRUIJNTJES J.P., VAN DER VEN J., BIEWENGA J. And SIMINIA T. - Lymphoid and non-lymphoid cells in nasal-associated lymphoid tissue (NALT) in the rat. An immuno-and enzyme -histochemical study. - Cell and Tissue Res., 29, 371-377, 1990.
12. GIANNASCA P.J., BODEN J.A. and MONATH T.P. - Targeted delivery of antigen to hamster nasal lymphoid tissue with M-cell directed lectins. - Infect. Immun., 65, 4288-4298, 1997.
13. WATANABE K., WATANABE I., SAITO Y. and MIZUHIRA V. -Characteristics of capillary permeability in nasal mucosa. -Annals Otology Rhinology and Laryngology, 87, 377-382, 1980.
14. NEUTRA M.R., PRINGAULT E. and KRAEHENBUHL J.P. -Antigen sampling across epithelial barriers and induction of mucosal immune responses. - Annu. Rev. Immunol., 14, 275-300, 1996.
15. BRANDENBERG P. - Immune functions of human nasal mucosa and tonsils in health. - In: Immunology of the Lung and Upper Respiratory Tract, J. Bienenstock Ed., McGraw-Hill, New York, 1984, pp. 28-95.
16. LI, V.H.K., ROBINSON, J.R. and LEE V.H.L. - Influence of drug properties and routes of drug administration on the design of sustained and controlled release systems. - In: Controlled Drug Delivery: Fundamentals and Applications, J.R. Robinson and V.H.L. Lee Eds., Marcel Dekker, New York, 1987, pp. 3-35.
17. PATTON J.S. - Mechanisms of macromolecule absorption by the lungs. - Adv. Drug Del. Rev., 19, 3-36, 1996.
18. SAYANI A.P. and CHIEN Y. W. - Systemic delivery of peptides and proteins across absorptive mucosae. - Crit. Rev. Ther. Drug Carrier Sys., 13, 85-184, 1996.
19. BIENENSTOCK J. - The lung as an immunologie organ. - Ann. Rev. Med., 35, 49-62, 1984.
20. HARMSEN A.G., MUGGENBERG B.A. and BICE D.E. - The role of macrophages in particle translocation from lungs to lymph nodes. - Science, 230, 1277-1280, 1985.
21. MESTECKY J. and McGHEE J.R. - Immunoglobulin A (IgA): Molecular and cellular interactions in IgA biosynthesis and immune response. - Advances in Immunol., 40, 153-245, 1987.
22. HOLMGREN J. and SVENNERHOLM A.M. - Practical aspects of protection at mucosal surfaces: oral vaccines against cholera and enterogenic Escherichia coli diarrhoea. - In: Bacterial Infections of the Respiratory and Gastrointestinal Mucosae, W. Donachie, E. Griffiths and J. Stephen Eds., IRL Press, Oxford, 1988, pp. 171-188.
23. HANEBERG B., KENDALL., AMERONGEN H.M., APTER F.M., KRAEHENBUHL J.P. and NEUTRA M.R. - Induction of specific immunoglobulin A in the small intestine, colon-rectum, and vagina measured by a new method for collection of secretions from mucosal surfaces. - Infect. Immun., 62, 15-23, 1994.
24. BERGQUIST C., JOHANSSON E., LAGERGARD T., HOLMGREN J. and RUDIN A. - Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina. - Infect. Immun., 65, 2676-2684, 1997.
25. MANZANEK M.B., LAMM M.E., LYN D., PORTNER A. And NEDRUD J.G. - Comparison of IgA verses IgG monoclonal antibodies for passive immunisation of the murine respiratory tract. - Virus Res., 23, 1-12, 1992.
26. ELDRIDGE J.H., STAAS J.K., MEULBROEK J.A., TICE T.R. and GILLEY R.M. - Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies. - Infect. Immun., 59, 2978-2986, 1991.
27. O'HAGAN D.T., OTT G.S. and VAN NEST G. - Recent advances in vaccine adjuvants: the development of MF59 emulsion and polymeric microparticles. - Mol. Med. Today, 3, 69-75, 1997.
28. WALKER R. I.-New strategies for using mucosal vaccination to achieve more effective immunisation. - Vaccine, 12, 387-400, 1994.
29. JENKINS P.G., COOMBES A.G.A., YEH M.K., THOMAS N.W. and DAVIS S. - Aspects of the design and delivery of microparticles for vaccine applications. - J. Drug Targeting, 3, 79-81, 1995.
30. NAKAOKA R., TABATA Y. and IKADA Y. - Adjuvant effect of biodegradable poly(DL-lactic acid) granules capable for antigen release following intraperitoneal injection. - Vaccine, 14, 1671-1676, 1996.
31. TABATA Y. and IKADA Y. - Phagocytosis of polymer microspheres by macrophages. - Adv. Polym. Sci., 94, 107-141, 1990.
32. TABATA Y., INOUE Y. and IKADA Y. - Size effect on systemic and mucosal immune responses induced by oral administartion of biodegradable microspheres. - Vaccine, 14, 1677-1685, 1996.
33. ELDRIDGE J.H., HAMMOND C.J., MEULBROEK J.A., STAAS J.K., GILLEY R.W. and TICE T.R. - Controlled vaccine released in the gut-associated lymphoid tissue. I: Orally administered biodegradable microspheres target the Peyer's patches. - J. Controlled Release, 11, 205-214, 1990.
34. KAGNOFF M.F. - Antigen handling by intestinal mucosa: humoral and cell mediated immunity, tolerance and genetic control of local immune responses. - In: Immunopathology of the Small Intestine, M.N. Marsh Ed., John Wiley, Winchester, 1987.
35. ELSON C.O. - Induction and control of the gastrointestinal immune system. - Scandinavian Journal of Immunology, 20, 1-20, 1985.
36. MANGANARO M., OGRA P.L. and ERNST P.B. - Oral immunization: turning fantasy into reality. - International Archives of Allergy and Applied Immunolog., 103, 223-230, 1994.
37. FLANAGAN M., JAIN S. and MICHAEL J.G. - Breaking of oral tolerence by an encapsulated antigen. - Annals of the New York Academy of Sciences, 778, 373-375, 1996.
38. O'HAGAN D.T. and ILLUM L. - Absorption of peptides and proteins from the respiratory tract and the potential for development of locally administered vaccine. - Crit. Rev. Ther. Drug Carrier Sys., 7, 35-97, 1990.
39. FLORENCE A.T. - The oral absorption of micro-and nanoparticulates: neither exceptional nor unusual. - Pharm. Res., 14, 259-266, 1997.
40. CONWAY B.R., EYLES J.E. and ALPAR H.O. - Systemic and local immune responses following oral and nasal delivery of microspheres of different sizes. - J. Pharm. Pharmacol., 49, (S4), 30, 1997.
41. CONWAY B.R. - The delivery of bioactive proteins using biodegradable microspheres. - PhD Thesis, Aston University, Birmingham, 1996.
42. CHALLACOMBE S.J., RAHMAN D. and O'HAGAN D.T. -Salivary, gut, vaginal and nasal antibody responses after oral immunization with biodegradable microparticles. - Vaccine, 15, 169-175, 1997.
43. BECK L.R., COWSAR D.R., LEWIS D.H., COSGROVE J.R., LOWRY S.L. and EPPERLY T.A. - A new long-acting microcapsule system for administration of progesterone. -Fertility Sterility, 31, 545-551, 1979.
44. ALPAR H.O. and ALMEIDA A.J. - Identification of some of the physiochemical characteristics of microspheres which influence the induction of the immune response following mucosal delivery. - Eur. J. Pharm. Biopharm., 40, 198-202, 1994.
45. ALPAR H.O., CONWAY B.R. AND BOWEN J.C. - The effect of formulation of PLA microspheres on immune responses: an in vivo study. - Proceed. Intern. Symp. Control. Rel. Bioact. Mater., Seattle, 22, 564-565, 1995.
46. CONWAY B.R., EYLES J.E. and ALPAR H.O. - A comparative study on the immune responses to antigens in PLA and PHB microspheres. - J. Con. Rel., 49, 1-9, 1997.
47. ALPAR H.O., AKBUGA J., EYLES J.E. AND WILLIAMSON E.D. - Immunological responses following oral and intramuscular administration of PLA microspheres manufactured using surfactants with adjuvant properties. - Proceed. Intern. Symp. Control. Rel. Bioact. Mater., Stockholm, 24, 785-786, 1997.
48. CONWAY B.R. and ALPAR H.O. - Double emulsion microencapsulation of proteins as model antigens using polylactide polymers: effect of emulsifier on the microsphere characteristics and release kinetics. - Eur. J. Pharm. Biopharm. 42, 42-48, 1996.
49. GHADERI R., STURESSON C. And CARLFORS J. - Effect of preparative parameters on the characteristics of poly (D,L-lactide-co-glycolide) microspheres made by the double emulsion method. - Int. J. Pharm., 141, 205-216, 1996.
50. HANES J. CLELAND J.L. and LANGER R. - New advances in microsphere-based single-dose vaccines. - Adv. Drug Del. Rev., 28, 97-119, 1997.
51. GUPTA R.K., CHANG A., GRIFFIN P., RIVERA R., GUO Y. and SIBER G.R. - Determination of protein loading in biodegradable polymer microspheres containing tetanus toxoid. - Vaccine, 15, 672-678, 1997.
52. SMITH P.K., KROHN R.I., HERMANSON G.T., MALLIA A.K., GARTNER F.H., PROVENZANO M.D., FUJIMOTO E.T., GOEKE, N.M., OLSON B.J. and KLENK D.C. - Measurement of proteins using bicinchoninic acid. - Analyt. Biochem., 150, 76-85, 1985.
53. ALLAOUI-ATTARKI K., PECQUET S., FATTAL E., TROLLE S., CHACHATY E., COUVREUR P. and ANDREMONT A. -Protective immunity against Salmonella typhimurium elicited in mice by oral vaccination with phosphorylcholine encapsulated in poly(D,L-lactide-co-glycolide) microspheres. - Infect. Immun., 65, 853-857, 1997.
54. SHARP G.J.E., EYLES J.E., WILLIAMSON E.D., BROWN M.R.W. and ALPAR H.O. - Cellular and humoral responses to microencapsulated Yersinia pestis subunit vaccines following oral delivery. - Biochem. Soc. Trans., 25, 338S, 1997.
55. STAATS H.F., JACKSON R.J., MARINARO M.,TAKAHASHI I., KIYONO H. and MCGHEE J.R. - Mucosal immunity to infection with implications for vaccine development. - Current Opinion in Immunology, 6, 572-580, 1994.
56. HUSBAND A.J. - Novel vaccination strategies for the control of mucosal infection. - Vaccine, 11, 107-115, 1993.
57. ALPAR H.O., ALMEIDA A.J., BROWN M.R.W. and WILLIAMSON E.D. - Mucosal and systemic immune response to intranasally and orally administered microencapsulated tetanus toxoid - Proceed. Intern. Symp. Control. Rel. Bioact. Mater., Nice, July 1994, 21, 867-868, 1994.
58. MUIR W., HUSBAND A.J., GIPPS E.M. and BRADLEY M.P. -Induction of specific IgA responses in rats after oral vaccination with biodegradable microspheres containing a recombinant protein. - Immunol. Lett., 42, 203-207, 1994.
59. JONES D.H., McBRIDE B.W., THORNTON C., O'HAGAN D.T., ROBINSON A. and FARRAR G.H. - Orally administered microencapsulated Bordetella pertussis fimbriae protect mice from B. pertussis respiratory infection. - Infect. Immun., 64, 489-494, 1996.
60. JACKSON R.J., STAATS H.F., XU-AMANO J., TAKAHASHI I., KIYONO H., HUDSON M.E., GILLEY R.M., CHATFIELD S.N. and McGHEE J.R. - Oral vaccine models: multiple delivery systems employing tetanus toxoid. - Annals of the New York Academy of Sciences, 730, 217-236, 1994.
61. SHAHIN R., LEEF M., ELDRIDGE J., HUDSON M. and GILLEY R. - Adjuvanticity and protective immunity elicited by Bordetella pertussis antigens encapsulated in poly(D,L-lactide-co-glycolide) microspheres. - Infect. Immun., 63, 1195-1200, 1995.
62. CAHILL E.S., O'HAGAN D.T., ILLUM L., BARNARD A., MILLS K.H.G. and REDHEAD K. - Immune responses and protection against Bordetella pertussis infection after intranasal immunization of mice with filamentous haemagglutinin in solution or incorporated in biodegradable microspheres. - Vaccine, 5, 455-462, 1995.
63. YAN C., RILL W., MALLI R., HEWETSON J., NASEEM H., TAMMARIELLO R. and KENDE M. - Intranasal stimulation of long-lasting immunity against aerosol ricin challenge with ricin toxoid vaccine encapsulated in polymeric microspheres. -Vaccine, 11, 1031-1038, 1996.
64. EYLES J.E., SHARP G.J.E., WILLIAMSON E.D., SPIERS I.D. and ALPAR H.O. - Intranasal administration of poly(lactic acid) microsphere coencapsulated Yersinia pestis subunits confers protection from pneumonic plague in the mouse. - Vaccine, 16, 698-707, 1998.
65. CARR R.M., LOLACHI C.M., ALBARAN R.G., RIDLEY D.M., MONTGOMERY P.C. and O'SULLIVAN N.L. - Nasal-associated lymphoid tissue is an inductive site for rat tear IgA antibody responses. - Immunol. Invest., 25, 387-396, 1996.
66. WILLIAMSON, E.D., ELEY, S.M., STAGG, A.J., GREEN, M.G., RUSSELL P. And TITBALL R.W. - A subunit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plague. -Vaccine, 15, 1079-1084, 1997.
67. HOLMGREN J. - Actions of cholera toxin and the prevention and treatment of cholera. - Nature, 292, 413-415, 1981.
68. DOUCHE G., FONTANA M., PIZZA M., RAPPUOLI R. and DOUGAN G. - Intranasal immunogenicity and adjuvanticity of site-directed mutant derivatives of cholera toxin. - Infect. Immun., 65, 2821-2828, 1997.
69. WU H.Y. And RUSSELL M.W. - Induction of mucosal and systemic imune responses by intranasal immunization using recombinant cholera toxin B subunit as an adjuvant. - Vaccine, 16, 286-292, 1998.
70. TOCHIKUBO K., ISAKA M., YASUDA Y., KOZUKA S., MATANO K., MIURA Y. and TANIGUCHI T. - Recombinant cholera toxin B subunit acts as an adjuvant for the mucosal and systemic responses of mice to mucosally co-administered bovine serum albumin. - Vaccine, 16, 150-155, 1998.
71. RUSSELL-JONES G. J. - Oral vaccination with lectins and lectin like molecules. - In: Novel Delivery Systems for Oral Vaccines, D.T. O'Hagan Ed., CRC Press, Boca Raton, 1994, 225-240.
72. ALMEIDA A.J. and ALPAR H.O. - Nasal delivery of vaccines. -J. Drug Targeting, 3, 455-465, 1996.
73. O'HAGAN D.T. - Novel Delivery Systems for Oral Vaccines. -CRC Press, Boca Raton, 1994.